# BNIP3

## Overview
BNIP3 (BCL2 interacting protein 3) is a gene that encodes a pro-apoptotic member of the Bcl-2 protein family, characterized by its BH3-only domain. The BNIP3 protein is a transmembrane protein that plays a pivotal role in regulating apoptosis and mitophagy, processes essential for maintaining cellular homeostasis and mitochondrial quality control. It is primarily localized to the mitochondria, where it interacts with various proteins to mediate cell death and autophagic pathways. BNIP3's involvement in these pathways is critical in both normal physiological processes and pathological conditions, such as cancer, heart disease, and neurodegenerative disorders. The gene's expression is often modulated by hypoxic conditions, which can influence its role in disease progression and cellular stress responses (Gorbunova2020BNIP3; Liu2022BNIP3; Chinnadurai2008BNIP3).

## Structure
The BNIP3 protein is a 194 amino acid long protein with a predicted molecular weight of 21.5 kDa. It migrates on SDS-PAGE as a monomer of 30 kDa and a homodimer of approximately 60 kDa (Vasagiri2014Structure). The primary structure of BNIP3 includes a PEST domain near the N-terminus, a BH3 domain, a conserved domain, and a C-terminal transmembrane (TM) domain (Vasagiri2014Structure). The BH3 domain, located between residues 110-118, is homologous to other Bcl-2 family members and is crucial for its pro-apoptotic activity (Vasagiri2014Structure).

The secondary structure of the BNIP3 TM domain primarily adopts an α-helical conformation when integrated into lipid bicelles (Bocharov2007Unique). The TM domain, spanning residues 164-184, contains a GXXXG motif essential for dimerization and forms strong stable dimers in membranes (Vasagiri2014Structure).

The quaternary structure of BNIP3 involves homodimerization, facilitated by a disulfide linkage at Cys64 and hydrogen bonding between His 173 and Ser 172 (Vasagiri2014Structure; Sulistijo2009Structural). The dimerization interface includes both polar and non-polar residues, with a significant hydrophilic motif formed by Ser 172 and His 173 (Bocharov2007Unique). The TM domain's unique dimeric structure suggests a mechanism for membrane permeabilization, potentially triggering cell death (Bocharov2007Unique).

## Function
BNIP3 (BCL2 interacting protein 3) is a BH3-only protein that plays a crucial role in maintaining mitochondrial homeostasis and pluripotency in embryonic stem cells (ESCs) through mitophagy, a process that removes damaged mitochondria. BNIP3 localizes to the mitochondria and contains a LC3 interacting region (LIR) motif necessary for the autophagic removal of mitochondria. Mutations in the LIR motif reduce mitochondrial autophagy without affecting BNIP3's pro-death activity. Reintroducing wild-type BNIP3 into BNIP3-deficient ESCs restores normal mitophagy, reduces abnormal mitochondrial accumulation, and normalizes reactive oxygen species (ROS) production and ATP generation, indicating its essential role in maintaining ESC identity and mitochondrial function (Liu2022BNIP3).

BNIP3 is also involved in mitochondrial clearance during somatic cell reprogramming, where somatic cells are converted into induced pluripotent stem cells (iPSCs). Knockdown of BNIP3 significantly decreases reprogramming efficiency, highlighting its critical role in both maintaining and inducing pluripotency (Liu2022BNIP3). In addition to its role in mitophagy, BNIP3 is implicated in regulating cellular proliferation. In certain cell types, BNIP3 expression reduces cell proliferation without affecting cell death levels, suggesting a role in controlling cell growth independently of cell death mechanisms (Singh2018The).

## Clinical Significance
BNIP3 is implicated in various diseases due to its role in cell death and autophagy. In cancer, BNIP3 expression is often altered, contributing to tumor progression and therapy resistance. It is highly expressed in hypoxic regions of tumors, such as breast and non-small cell lung cancer, where it is associated with poor prognosis and increased metastatic potential (Gorbunova2020BNIP3; Chinnadurai2008BNIP3). In pancreatic cancer, BNIP3 expression is frequently silenced by promoter hypermethylation, which is linked to tumor progression and chemoresistance. Restoring its expression can induce apoptosis in pancreatic cancer cell lines (Vasagiri2014Structure; Chinnadurai2008BNIP3).

In heart disease, BNIP3 is upregulated during ischemia, contributing to cardiomyocyte death and heart failure. Its expression is associated with mitochondrial dysfunction and cell death through necrosis and autophagy (Chinnadurai2008BNIP3; Burton2009The). BNIP3 is also involved in neurodegenerative diseases, where it contributes to neuronal cell death following ischemic injury (Vasagiri2014Structure). The gene's regulation by hypoxia-inducible factors and its involvement in mitophagy highlight its role in maintaining cellular homeostasis under stress conditions (Gorbunova2020BNIP3; Gao2020Bnip3).

## Interactions
BNIP3, a pro-apoptotic member of the Bcl-2 protein family, is involved in several critical protein interactions that influence apoptosis and mitophagy. BNIP3 contains a BH3 domain, which is essential for its interaction with anti-apoptotic proteins such as BCL-2, BCL-xL, E1B-19K, and EBV-BHRF1. These interactions are crucial for BNIP3's role in promoting apoptosis, as the BH3 domain facilitates heterodimerization with these proteins, thereby antagonizing their anti-apoptotic effects (Chinnadurai2008BNIP3; Yasuda1998Adenovirus).

BNIP3 also interacts with LC3, a protein associated with autophagosomes, to regulate mitophagy. This interaction is particularly significant in the context of ischemic stroke, where BNIP3's binding to LC3 triggers excessive mitophagy, contributing to delayed neuronal death. The interaction between BNIP3 and LC3 is enhanced following ischemia/hypoxia injury, highlighting BNIP3's role in mitochondrial quality control and cell death pathways (Shi2014BNIP3).

BNIP3 can form homodimers through interactions at its COOH terminus, which is crucial for its mitochondrial localization and apoptotic function. This dimerization is necessary for BNIP3's ability to induce apoptosis, even in the presence of anti-apoptotic signals from proteins like BCL-2 (Chen1997The).


## References


[1. (Gao2020Bnip3) Anbo Gao, Jinyong Jiang, Feng Xie, and Linxi Chen. Bnip3 in mitophagy: novel insights and potential therapeutic target for diseases of secondary mitochondrial dysfunction. Clinica Chimica Acta, 506:72–83, July 2020. URL: http://dx.doi.org/10.1016/j.cca.2020.02.024, doi:10.1016/j.cca.2020.02.024. This article has 106 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cca.2020.02.024)

[2. (Liu2022BNIP3) Kun Liu, Qian Zhao, Hongyan Sun, Lei Liu, Chaoqun Wang, Zheng Li, Youqing Xu, Liang Wang, Lin Zhang, Honghai Zhang, Quan Chen, and Tongbiao Zhao. Bnip3 (bcl2 interacting protein 3) regulates pluripotency by modulating mitochondrial homeostasis via mitophagy. Cell Death &amp; Disease, April 2022. URL: http://dx.doi.org/10.1038/s41419-022-04795-9, doi:10.1038/s41419-022-04795-9. This article has 14 citations.](https://doi.org/10.1038/s41419-022-04795-9)

[3. (Chen1997The) Gao Chen, Reena Ray, Don Dubik, Lianfa Shi, Jeannick Cizeau, R. Chris Bleackley, Satya Saxena, R. Dan Gietz, and Arnold H. Greenberg. The e1b 19k/bcl-2–binding protein nip3 is a dimeric mitochondrial protein that activates apoptosis. The Journal of Experimental Medicine, 186(12):1975–1983, December 1997. URL: http://dx.doi.org/10.1084/jem.186.12.1975, doi:10.1084/jem.186.12.1975. This article has 273 citations.](https://doi.org/10.1084/jem.186.12.1975)

[4. (Sulistijo2009Structural) Endah S. Sulistijo and Kevin R. MacKenzie. Structural basis for dimerization of the bnip3 transmembrane domain,. Biochemistry, 48(23):5106–5120, May 2009. URL: http://dx.doi.org/10.1021/bi802245u, doi:10.1021/bi802245u. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi802245u)

[5. (Gorbunova2020BNIP3) Anna S. Gorbunova, Maria A. Yapryntseva, Tatiana V. Denisenko, and Boris Zhivotovsky. Bnip3 in lung cancer: to kill or rescue? Cancers, 12(11):3390, November 2020. URL: http://dx.doi.org/10.3390/cancers12113390, doi:10.3390/cancers12113390. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers12113390)

[6. (Singh2018The) Amandeep Singh, Meghan Azad, Miriam D. Shymko, Elizabeth S. Henson, Sachin Katyal, David D. Eisenstat, and Spencer B. Gibson. The bh3 only bcl-2 family member bnip3 regulates cellular proliferation. PLOS ONE, 13(10):e0204792, October 2018. URL: http://dx.doi.org/10.1371/journal.pone.0204792, doi:10.1371/journal.pone.0204792. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0204792)

[7. (Yasuda1998Adenovirus) Motoaki Yasuda, Paul Theodorakis, T. Subramanian, and G. Chinnadurai. Adenovirus e1b-19k/bcl-2 interacting protein bnip3 contains a bh3 domain and a mitochondrial targeting sequence. Journal of Biological Chemistry, 273(20):12415–12421, May 1998. URL: http://dx.doi.org/10.1074/jbc.273.20.12415, doi:10.1074/jbc.273.20.12415. This article has 180 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.273.20.12415)

[8. (Shi2014BNIP3) Ruo‐Yang Shi, Sheng‐Hua Zhu, Victor Li, Spencer B. Gibson, Xing‐Shun Xu, and Ji‐Ming Kong. Bnip3 interacting with lc3 triggers excessive mitophagy in delayed neuronal death in stroke. CNS Neuroscience &amp; Therapeutics, 20(12):1045–1055, September 2014. URL: http://dx.doi.org/10.1111/cns.12325, doi:10.1111/cns.12325. This article has 197 citations.](https://doi.org/10.1111/cns.12325)

[9. (Chinnadurai2008BNIP3) G Chinnadurai, S Vijayalingam, and S B Gibson. Bnip3 subfamily bh3-only proteins: mitochondrial stress sensors in normal and pathological functions. Oncogene, 27(S1):S114–S127, December 2008. URL: http://dx.doi.org/10.1038/onc.2009.49, doi:10.1038/onc.2009.49. This article has 159 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2009.49)

[10. (Burton2009The) T R Burton and S B Gibson. The role of bcl-2 family member bnip3 in cell death and disease: nipping at the heels of cell death. Cell Death &amp; Differentiation, 16(4):515–523, January 2009. URL: http://dx.doi.org/10.1038/cdd.2008.185, doi:10.1038/cdd.2008.185. This article has 160 citations.](https://doi.org/10.1038/cdd.2008.185)

[11. (Bocharov2007Unique) Eduard V. Bocharov, Yulia E. Pustovalova, Konstantin V. Pavlov, Pavel E. Volynsky, Marina V. Goncharuk, Yaroslav S. Ermolyuk, Dmitry V. Karpunin, Alexey A. Schulga, Michail P. Kirpichnikov, Roman G. Efremov, Innokenty V. Maslennikov, and Alexander S. Arseniev. Unique dimeric structure of bnip3 transmembrane domain suggests membrane permeabilization as a cell death trigger. Journal of Biological Chemistry, 282(22):16256–16266, June 2007. URL: http://dx.doi.org/10.1074/jbc.M701745200, doi:10.1074/jbc.m701745200. This article has 175 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M701745200)

[12. (Vasagiri2014Structure) Nagarjuna Vasagiri and Vijay Kumar Kutala. Structure, function, and epigenetic regulation of bnip3: a pathophysiological relevance. Molecular Biology Reports, 41(11):7705–7714, August 2014. URL: http://dx.doi.org/10.1007/s11033-014-3664-x, doi:10.1007/s11033-014-3664-x. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11033-014-3664-x)